Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cocrystal Pharma, Inc. | Director | Stock Options (Right to Buy) | 24.4K | Jul 18, 2023 | Direct | ||
Xenetic Biosciences, Inc. | Director | Stock Options | 2.5K | Dec 6, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XBIO | Xenetic Biosciences, Inc. | Dec 6, 2023 | 1 | $0 | 4 | Dec 8, 2023 | Director |
COCP | Cocrystal Pharma, Inc. | Jul 18, 2023 | 1 | $0 | 4 | Jul 20, 2023 | Director |
XBIO | Xenetic Biosciences, Inc. | Dec 7, 2022 | 1 | $0 | 4 | Dec 9, 2022 | Director |
COCP | Cocrystal Pharma, Inc. | Jul 25, 2022 | 1 | $0 | 4 | Aug 3, 2022 | Director |
XBIO | Xenetic Biosciences, Inc. | Dec 7, 2021 | 1 | $0 | 4 | Dec 9, 2021 | Director |
COCP | Cocrystal Pharma, Inc. | Jul 16, 2021 | 1 | $0 | 4 | Jul 20, 2021 | Director |